Clinical Trial: Effects of Sequential Therapy With Mexidol(R) (Intravenous) and Mexidol(R) FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders

U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07923240) titled 'Effects of Sequential Therapy With Mexidol(R) (Intravenous) and Mexidol(R) FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders' on Oct. 19.

Brief Summary: We aim to elucidate the metabolic and neuroactive properties of sequential Mexidol therapy in patients with and without cerebrometabolic disorders using blood biomarkers, anthropometry and brain functional MRI (task- and rest).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Metabolic Ab...